Next Article in Journal
Development of Novel Vaccines against Enterovirus-71
Next Article in Special Issue
PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival
Previous Article in Journal
TRIM19/PML Restricts HIV Infection in a Cell Type-Dependent Manner
Previous Article in Special Issue
Recent Advances in Therapeutic Approaches for Adult T-cell Leukemia/Lymphoma
 
 
Review

HTLV-1, Immune Response and Autoimmunity

1
Science Center of Health and Biology. Pará State University, Rua Perebebuí, 2623, Belém, Pará 66087-670, Brazil
2
Science Health Institute, Federal University of Pará, Praça Camilo Salgado, 1, Belém, Pará 66055-240, Brazil
3
Tropical Medicine Center, Federal University of Pará, Av. Generalíssimo Deodoro, 92, Belém, Pará 66055-240, Brazil
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Louis M. Mansky
Viruses 2016, 8(1), 5; https://doi.org/10.3390/v8010005
Received: 18 October 2015 / Revised: 27 November 2015 / Accepted: 14 December 2015 / Published: 24 December 2015
(This article belongs to the Special Issue Recent Advances in HTLV Research 2015)
Human T-lymphotropic virus type-1 (HTLV-1) infection is associated with adult T-cell leukemia/lymphoma (ATL). Tropical spastic paraparesis/HTLV-1-associated myelopathy (PET/HAM) is involved in the development of autoimmune diseases including Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Sjögren’s Syndrome (SS). The development of HTLV-1-driven autoimmunity is hypothesized to rely on molecular mimicry, because virus-like particles can trigger an inflammatory response. However, HTLV-1 modifies the behavior of CD4+ T cells on infection and alters their cytokine production. A previous study showed that in patients infected with HTLV-1, the activity of regulatory CD4+ T cells and their consequent expression of inflammatory and anti-inflammatory cytokines are altered. In this review, we discuss the mechanisms underlying changes in cytokine release leading to the loss of tolerance and development of autoimmunity. View Full-Text
Keywords: Human T-lymphotropic virus type-1 (HTLV-1); immune response; autoimmunity Human T-lymphotropic virus type-1 (HTLV-1); immune response; autoimmunity
Show Figures

Figure 1

MDPI and ACS Style

Quaresma, J.A.S.; Yoshikawa, G.T.; Koyama, R.V.L.; Dias, G.A.S.; Fujihara, S.; Fuzii, H.T. HTLV-1, Immune Response and Autoimmunity. Viruses 2016, 8, 5. https://doi.org/10.3390/v8010005

AMA Style

Quaresma JAS, Yoshikawa GT, Koyama RVL, Dias GAS, Fujihara S, Fuzii HT. HTLV-1, Immune Response and Autoimmunity. Viruses. 2016; 8(1):5. https://doi.org/10.3390/v8010005

Chicago/Turabian Style

Quaresma, Juarez A S, Gilberto T Yoshikawa, Roberta V L Koyama, George A S Dias, Satomi Fujihara, and Hellen T Fuzii. 2016. "HTLV-1, Immune Response and Autoimmunity" Viruses 8, no. 1: 5. https://doi.org/10.3390/v8010005

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop